Analgesic effects of an ethanol extract of the fruits of Xylopia aethiopica (Dunal) A. Rich (Annonaceae) and the major constituent, xylopic acid in murine models

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue 4, 2012, Pages 291-301

  Woode, Eric ^a   Ameyaw, Elvis O ^a   Boakye Gyasi, Eric ^a   Abotsi, Wonder K M ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Formalin test; kaurene diterpenes; opioid tolerance; pain; Xylopic acid

Indexed keywords

ACETIC ACID; ALCOHOL; DICLOFENAC; DITERPENE; FORMALDEHYDE; MORPHINE; PLANT EXTRACT; UNCLASSIFIED DRUG; XYLOPIA AETHIOPOCA FRUIT EXTRACT; XYLOPIC ACID;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANNONACEAE; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG CROSS TOLERANCE; DRUG STRUCTURE; DRUG TOLERANCE; FEMALE; FRUIT; HYPERALGESIA; LIMB PAIN; MALE; MORPHINE TOLERANCE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; WRITHING TEST; XYLOPIA; XYLOPIA AETHIOPICA;

ANIMALIA; ANNONACEAE; MURINAE; XYLOPIA AETHIOPICA;

EID: 84870223631     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.103251     Document Type: Article

References (61)

1. Schim JD, Stang P. Overview of pain management. Pain Pract 2004;4(Suppl 1):S4-18.
2. McMahon SB, Koltzenburg M. Wall and Melzack's textbook of pain. 5 th ed. Edinburgh: Elsevier/Churchill Livingstone; 2006. p300-350
3. Chen CH, Tang ST, Chen CH. Meta-analysis of cultural differences in Western and Asian patient-perceived barriers to managing cancer pain. Palliat Med 2012;26:206-21.
4. Bandolier. Bandolier: Acute pain. Bandolier Extra February 2003:1-22.
5. Igwe SA, Afonne JC, Ghasi SI. Ocular dynamics of systemic aqueous extracts of Xylopia aethiopica (African guinea pepper) seeds on visually active volunteers. J Ethnopharmacol 2003;86:139-42.
6. Burkill HM. The useful plants of west tropical africa. A revision of dalziel, vol. II, 2 nd ed. Families A-D Royal Botanical Garden, Kent,p. 130-132.
7. Boakye-Yiadom K, Fiagbe NI, Ayim JS. Antimicrobial properties of some West African medicinal plants iv. Antimicrobial activity of xylopic acid and other constituents of the fruits of Xylopia aethiopica (Annonaceae). Lloydia 1977;40:543-5.
8. Ekong DE, Ogan AU. Chemistry of the constituents of Xylopia aethiopica. The structure of xylopic acid, a new diterpene acid. J Chem Soc C: Organic 1968; 311-2.
9. Bresciani LF, Yunes RA, Burger C, De Oliveira LE, Bof KL, Cechinel-Filho V. Seasonal variation of kaurenoic acid, a hypoglycemic diterpene present in Wedelia paludosa (Acmela brasiliensis) (Asteraceae). Z Naturforsch C 2004;59:229-32.
10. Ghisalberti EL. The biological activity of naturally occurring kaurane diterpenes. Fitoterapia 1997;68:303.
11. Garcia PA, de Oliveira AB, Batista R. Occurrence, biological activities and synthesis of kaurane diterpenes and their glycosides. Molecules 2007;12:455-83.
12. Castrillo A, de Las Heras B, Hortelano S, Rodriguez B, Villar A, Bosca L. Inhibition of the nuclear factor kappa B (NF-kappa B) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-kappa B-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK. J Biol Chem 2001;276:15854-60.
13. Block LC, Santos AR, de Souza MM, Scheidt C, Yunes RA, Santos MA, et al. Chemical and pharmacological examination of antinociceptive constituents of Wedelia paludosa. J Ethnopharmacol 1998;61:85-9.
14. Somova LI, Shode FO, Moodley K, Govender Y. Cardiovascular and diuretic activity of kaurene derivatives of Xylopia aethiopica and Alepidea amatymbica. J Ethnopharmacol 2001;77:165-74.
15. Sosa-Sequera MC, Suarez O, Dalo NL. Kaurenic acid: An in vivo experimental study of its anti-inflammatory and antipyretic effects. Indian J Pharmacol 2010;42:293-6.
16. Davino SC, Giesbrecht AM, Roque NF. Antimicrobial activity of kaurenoic acid derivatives substituted on carbon-15. Braz J Med Biol Res 1989;22:1127-9.
17. Abaidoo CS, Woode E, Alhassan A. An evaluation of the effect of ethanolic fruit extracts of Xylopia aethiopica on haematological and biochemical parameters in male rats. Der Pharmacia Sinica 2011;2:39-45.
18. Tang L, Chen Y, Chen Z, Blumberg PM, Kozikowski AP, Wang ZJ. Antinociceptive pharmacology of N-(4-chlorobenzyl)-N'-(4-hydroxy-3-iodo-5- methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor. J Pharmacol Exp Ther 2007;321:791-8.
19. Koster R, Anderson M, Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959;18:412-8.
20. Dubuisson D, Dennis SG. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977;4:161-74.
21. Woode E, Poku RA, Ainooson GK, Boakye-Gyasi E, Abotsi WK, Mensah TL, et al. An evaluation of the anti-inflammatory, antipyretic and antinociceptive effects of ficus exasperata (Vahl) leaf extract. J Pharmaco Toxicol 2009;4:138-51.
22. Fecho K, Nackley AG, Wu Y, Maixner W. Basal and carrageenan-induced pain behavior in Sprague-Dawley, Lewis and Fischer rats. Physiol Behav 2005;85:177-86.
23. Stohr T, Krause E, Selve N. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain. Eur J Pain 2006;10:241-9.
24. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957;111:409-19.
25. Galbraith JA, Mrosko BJ, Myers RR. A system to measure thermal nociception. J Neurosci Methods 1993;49:63-8.
26. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
27. Gareri P, Condorelli D, Belluardo N, Citraro R, Barresi V, Trovato-Salinaro A, et al. Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology 2005;49:551-63.
28. Miller Jr. GraphPad Version 4.0. Step-by-Step Examples. San Diego, CA: GraphPad Software Inc.; 2003. p 55-69
29. Motulsky HJ, Christopoulos A. Fitting model to biological data using linear and nonlinear regression. A practical guide to curve fitting. San Diego, CA: GraphPad Software Inc.; 2003.p 13-46
30. Pietrovski EF, Rosa KA, Facundo VA, Rios K, Marques MC, Santos AR. Antinociceptive properties of the ethanolic extract and of the triterpene 3beta,6beta,16beta-trihidroxilup-20(29)-ene obtained from the flowers of Combretum leprosum in mice. Pharmacol Biochem Behav 2006;83:90-9.
31. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001;413:203-10.
32. dos Santos DA, Fukui Mde J, Dhammika Nanayakkara NP, Khan SI, Sousa JP, Bastos JK, et al. Anti-inflammatory and antinociceptive effects of Baccharis dracunculifolia DC (Asteraceae) in different experimental models. J Ethnopharmacol;127:543-50.
33. Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH, et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000;387:111-8.
34. Deraedt R, Jouquey S, Delevallee F, Flahaut M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 1980 61:17-24.
35. Duarte ID, Nakamura M, Ferreira SH. Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res 1988;21:341-3.
36. Raja SN, Meyer RA, Campbell JN. Peripheral mechanisms of somatic pain. Anesthesiology 1988;68:571-90.
37. Panthong A, Norkaew P, Kanjanapothi D, Taesotikul T, Anantachoke N, Reutrakul V. Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook f. J Ethnopharmacol 2007;111:335-40.
38. Ferreira SH, Nakamura M. II-Prostaglandin hyperalgesia: The peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins 1979;18:191-200.
39. Levine JD, Taiwo YO. Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience 1989;32:571-5.
40. Park H-J, Kim I-T, Won J-H, Jeong S-H, Park E-Y, Nam J-H, et al. Anti-inflammatory activities of ent-16[alpha]H,17-hydroxy-kauran-19-oic acid isolated from the roots of Siegesbeckia pubescens are due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-[kappa]B inactivation. Eur J Pharmacol 2007;558:185-93.
41. Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens. Mol Pharmacol 2005;68:286-97.
42. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: An evaluation of the method. Pain 1992;51:5-17.
43. Hunskaar S, Hole K. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain 1987;30:103-14.
44. Santa-Cecilia FV, Vilela FC, da Rocha CQ, Dias DF, Cavalcante GP, Freitas LA, et al. Anti-inflammatory and antinociceptive effects of Garcinia brasiliensis. J Ethnopharmacol 2011;133:467-73.
45. da Rocha CQ, Vilela FC, Cavalcante GP, Santa-Cecilia FV, Santos-e-Silva L, dos Santos MH, et al. Anti-inflammatory and antinociceptive effects of Arrabidaea brachypoda (DC.) Bureau roots. J Ethnopharmacol 2011;133:396-401.
46. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: Characteristic biphasic pain response. Pain 1989;38:347-52.
47. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: An overview. Pain 1985; 22:1-31.
48. Jensen TS, Yaksh TL. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res 1986;363:99-113.
49. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361:184-7.
50. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995;75:125-31.
51. Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol 2003;225:115-21.
52. Peskar BM, Trautmann M, Nowak P, Peskar BA. Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: Effect of non-steroidal anti-inflammatory drugs. Agents Actions 1991;33:240-6.
53. Rueff A, Dray A. Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience 1993;54:527-35.
54. Singh VP, Patil CS, Kulkarni SK. Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats. Pharmacol Biochem Behav 2005;81:433-9.
55. Collier HO, Schneider C. Nociceptive response to prostaglandins and analgesic actions of aspirin and morphine. Nat New Biol 1972;236:141-3.
56. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, et al. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 2004;19:3375-81.
57. Haddad JJ. Cellular and molecular regulation of inflammatory pain, nociception and hyperalgesia-The role of the transcription factor NF-B as the lynchpin nocisensor: Hyperalgesic or analgesic effect? Curr Immunol Rev 2007;3:117-31.
58. Baeuerle PA. IkappaB-NF-kappaB structures: At the interface of inflammation control. Cell 1998;95:729-31.
59. Tang L, Shukla PK, Wang LX, Wang ZJ. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II. J Pharmacol Exp Ther 2006;317:901-9.
60. Chen Y, Geis C, Sommer C. Activation of TRPV1 contributes to morphine tolerance: Involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci 2008;28:5836-45.
61. Dalo NL, Sosa-Sequera MC, Usubillaga A. On the anticonvulsant activity of kaurenic acid. Invest Clin 2007;48:349-58.